PPBP and mucopolysaccharidosis type 6: For MPSVI patients, only subjects of 4 years of age and older are eligible in the Phase I/II clinical trial using the liver-directed AAV8-TGB-hARSB gene therapy (ClinicalTrials.gov Identifier: NCT03173521).